Spontaneous and induced differentiation of human melanoma cells. 1993

I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.

Malignant melanoma cells can differentiate spontaneously in vivo and in vitro into cells with a finite lifespan. Analysis of differentiating cells from primary melanomas in culture revealed a flat, fibroblast-like morphology and expression of the fibroblast-associated marker leucine aminopeptidase (LAP). Differentiation was also observed in a minor sub-population of permanent cell lines derived from metastatic lesions. An experimental model of melanoma cell differentiation was then developed, using the pyrimidine analog bromodeoxyuridine (BUdR). BUdR-treated cells had a flat morphology, were contact-inhibited, had up to 20-fold increased surface area, expressed LAP, no longer proliferated anchorage-independently in soft agar, and 3 out of 4 cell lines were non-tumorigenic in athymic nude mice. Our results show that models of differentiation of melanoma cells can be established that help to define pathways of differentiation.

UI MeSH Term Description Entries
D007931 Leucyl Aminopeptidase A zinc containing enzyme of the hydrolase class that catalyzes the removal of the N-terminal amino acid from most L-peptides, particularly those with N-terminal leucine residues but not those with N-terminal lysine or arginine residues. This occurs in tissue cell cytosol, with high activity in the duodenum, liver, and kidney. The activity of this enzyme is commonly assayed using a leucine arylamide chromogenic substrate such as leucyl beta-naphthylamide. Cytosol Aminopeptidase,Leucine Aminopeptidase,L-Leucylnaphthylamidase,Methoxyleucine Aminopeptidase,Peptidase S,Zinc-Manganese-Leucine Aminopeptidase,Aminopeptidase, Cytosol,Aminopeptidase, Leucine,Aminopeptidase, Leucyl,Aminopeptidase, Methoxyleucine,Aminopeptidase, Zinc-Manganese-Leucine,Zinc Manganese Leucine Aminopeptidase
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA

Related Publications

I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
September 1975, Journal of the National Cancer Institute,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
December 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
January 2005, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
March 2002, Journal of anatomy,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
January 1990, Cancer communications,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
April 1983, Biulleten' eksperimental'noi biologii i meditsiny,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
January 2022, In vivo (Athens, Greece),
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
September 1994, The Journal of investigative dermatology,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
April 2009, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
I Valyi-Nagy, and I M Shih, and T Györfi, and D Greenstein, and I Juhasz, and D E Elder, and M Herlyn
January 1996, Yao xue xue bao = Acta pharmaceutica Sinica,
Copied contents to your clipboard!